Timothy Surber
Oral and Maxillofacial Surgery · Indianapolis, INNPI 1144668989
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,886 of the $14,193 with a category attached, or 62.6%. Straumann USA LLC accounts for 90.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $12,177, more than ten times the $71 reported in 2019. Among oral and maxillofacial surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $155.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$13K
- Biohorizons Implant Systems Inc.$1K
- Kls-martin L.p.$125
- Align Technology, Inc.$21
- Geistlich Pharma, North America, Inc.$12
What the payments were for
- Consulting fees$8,88663%
- Travel & lodging$1,0167%
- Food & beverage$3,74126%
- Education$5504%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 60 | $12,811 |
| Biohorizons Implant Systems Inc. | 28 | $1,223 |
| Kls-martin L.p. | 1 | $125 |
| Align Technology, Inc. | 1 | $21 |
| Geistlich Pharma, North America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOHORIZONS$2,626
How this compares
$14,193 in reported general payments places this provider in the 95th percentile of 127 oral and maxillofacial surgery providers in Indiana.
See all oral and maxillofacial surgery providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 187 | $653 |
| Clindamycin Hcl | 36 | $305 |
| Amoxicillin | 114 | $267 |
| Ibuprofen | 76 | $179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $144 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Indianapolis
- Waldemar PolidoIndianapolis$145K
- Charles AbrahamIndianapolis$5K
- Patrick KellyIndianapolis$5K
- Christopher BurnsIndianapolis$4K
- Nicholas WegnerIndianapolis$3K
- Paramjeet SagooIndianapolis$2K
- Mark McDonoughIndianapolis$2K
- John SchierIndianapolis$2K
- Nikolas WasylykIndianapolis$2K
- Robinpreet PannuIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.